louisiana glp-1 ileus law office firm in 🚨 The Obesity Society Brings Urgent GLP -1 Safety Weight Loss in Chalmette louisiana semaglutide bowel obstruction lawsuit

In a parallel study of those on weight loss medicines, researchers compared about 171,000 who were on GLP-1 medications with about 197,000 who were on other weight loss drugs, and found that liraglutide (Saxenda) more than doubled the incidence of delayed gastric emptying, and that semaglutide (Wegovy) increased this side effect by more than a third (39%) compared to non-GLP-1 drugs

Missing doses allows blood glucose levels to rise, potentially leading to hyperglycemic symptoms including increased thirst, frequent urination, fatigue, and blurred vision

Diabetes Care 46 , 801810 (2023)

utide&phase=2&rank=5

Understanding GLP-1: The Billion-Dollar Opportunity GLP-1 receptor agonists represent advanced peptide-based drugs used to manage Type 2 diabetes and obesity